Recently, DKSH Holding AG (DiKe Shares) announced that it has officially filed a lawsuit against two companies for alleged intellectual property infringement and unfair competition. According to the company’s public statement, the defendants are accused of using DKSH’s proprietary technologies without authorization and marketing highly similar products, thereby significantly harming DKSH’s commercial interests and brand reputation. DKSH emphasized that this legal action aims to protect its legitimate rights and underscores its firm commitment to technological innovation and intellectual property protection. The company stated it has gathered substantial evidence and will fully cooperate with judicial proceedings to hold the responsible parties legally accountable. Industry observers note that this move not only helps clarify market order but may also serve as a warning to others in the sector about the importance of IP compliance. As a leading global distributor of specialty chemicals and life sciences products, DKSH has long prioritized R&D and regulatory compliance, and this litigation reflects its determination to uphold fairness and the rule of law amid intense market competition.
近日，帝科股份（DKSH Holding AG）宣布已正式向法院提起诉讼，起诉两家公司涉嫌侵犯其知识产权及不正当竞争行为。据公司公告，涉事企业被指控未经授权使用帝科股份的核心技术，并在市场上销售高度相似的产品，严重损害了帝科的商业利益与品牌声誉。帝科股份强调，此次诉讼旨在维护自身合法权益，同时彰显其对技术创新和知识产权保护的坚定立场。公司表示，已掌握充分证据，并将全力配合司法程序，追究相关方的法律责任。业内人士指出，此举不仅有助于厘清市场秩序，也可能对行业内的知识产权合规意识起到警示作用。帝科股份作为全球领先的特种化学品与生命科学产品分销服务商，长期致力于研发与合规经营，此次法律行动也体现了其在激烈市场竞争中坚持法治与公平原则的决心。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/22294.html